Renaissance Technologies’s Stealth BioTherapeutics Corp. ADS MITO Stock Holding History

Renaissance Technologies’s Portfolio MITO Stock Details MITO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-96,944	Closed	-$30K	–	4562
2022 Q3	$30K	Buy	96,944 +82,175	+556%	+$23.4K	﹤0.01%	3848
2022 Q2	$4K	Sell	14,769 -32,008	-68%	-$11K	﹤0.01%	4172
2022 Q1	$33K	Sell	46,777 -10,473	-18%	-$7.08K	﹤0.01%	3959
2021 Q4	$48K	Sell	57,250 -9,827	-15%	-$10.2K	﹤0.01%	3787
2021 Q3	$91K	Sell	67,077 -14,800	-18%	-$20.1K	﹤0.01%	3332
2021 Q2	$128K	Sell	81,877 -799,469	-91%	-$1.12M	﹤0.01%	3330
2021 Q1	$1.38M	Buy	881,346 +313,182	+55%	+$538K	﹤0.01%	2444
2020 Q4	$849K	Buy	568,164 +478,903	+537%	+$672K	﹤0.01%	2584
2020 Q3	$121K	Sell	89,261 -166,296	-65%	-$285K	﹤0.01%	3185
2020 Q2	$468K	Buy	255,557 +127,757	+100%	+$233K	﹤0.01%	2907
2020 Q1	$158K	Buy	+127,800	New	+$284K	﹤0.01%	3144

Renaissance Technologies's MITO Position: Q4 2022 in Review

Renaissance Technologies sold out of Stealth BioTherapeutics Corp. ADS (MITO) in Q4 2022, closing a stake of 96,944 shares — an estimated $30K sold.

Renaissance Technologies first reported a position in MITO in Q1 2020 and held it in 11 quarters. The position peaked at $1.38M in Q1 2021. 0 funds tracked by Wall St. Rank hold MITO as of Q4 2022.

Renaissance Technologies reported no remaining Stealth BioTherapeutics Corp. ADS position as of Q4 2022 after selling out during the quarter.
Renaissance Technologies sold 96,944 Stealth BioTherapeutics Corp. ADS shares in Q4 2022, an estimated $30K.
Renaissance Technologies first reported a position in Stealth BioTherapeutics Corp. ADS in Q1 2020 and held it in 11 quarters.
Renaissance Technologies's Stealth BioTherapeutics Corp. ADS position peaked at $1.38M in Q1 2021.
0 funds tracked by Wall St. Rank held Stealth BioTherapeutics Corp. ADS as of Q4 2022.

Based on Renaissance Technologies's 13F filing for Q4 2022, filed 13 Feb 2023.